The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Single Cell Multi-Omics Market Research Report 2024
Synopsis
Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
The global Single Cell Multi-Omics market was valued at US$ 1810.6 million in 2023 and is anticipated to reach US$ 3485.8 million by 2030, witnessing a CAGR of 9.3% during the forecast period 2024-2030.
North American market for Single Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single Cell Multi-Omics in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single Cell Multi-Omics include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee and BGI Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Cell Multi-Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multi-Omics.
Report Scope
The Single Cell Multi-Omics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Cell Multi-Omics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cell Multi-Omics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Segment by Type
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Segment by Application
Oncology
Cell Biology
Neurology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Cell Multi-Omics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
The global Single Cell Multi-Omics market was valued at US$ 1810.6 million in 2023 and is anticipated to reach US$ 3485.8 million by 2030, witnessing a CAGR of 9.3% during the forecast period 2024-2030.
North American market for Single Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single Cell Multi-Omics in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single Cell Multi-Omics include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee and BGI Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Cell Multi-Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multi-Omics.
Report Scope
The Single Cell Multi-Omics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Cell Multi-Omics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cell Multi-Omics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Segment by Type
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Segment by Application
Oncology
Cell Biology
Neurology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Cell Multi-Omics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Multi-Omics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Cell Genomics
1.2.3 Single Cell Proteomics
1.2.4 Single Cell Transcriptomics
1.2.5 Single Cell Metabolomics
1.3 Market by Application
1.3.1 Global Single Cell Multi-Omics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cell Biology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Multi-Omics Market Perspective (2019-2030)
2.2 Single Cell Multi-Omics Growth Trends by Region
2.2.1 Global Single Cell Multi-Omics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single Cell Multi-Omics Historic Market Size by Region (2019-2024)
2.2.3 Single Cell Multi-Omics Forecasted Market Size by Region (2025-2030)
2.3 Single Cell Multi-Omics Market Dynamics
2.3.1 Single Cell Multi-Omics Industry Trends
2.3.2 Single Cell Multi-Omics Market Drivers
2.3.3 Single Cell Multi-Omics Market Challenges
2.3.4 Single Cell Multi-Omics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Multi-Omics Players by Revenue
3.1.1 Global Top Single Cell Multi-Omics Players by Revenue (2019-2024)
3.1.2 Global Single Cell Multi-Omics Revenue Market Share by Players (2019-2024)
3.2 Global Single Cell Multi-Omics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell Multi-Omics Revenue
3.4 Global Single Cell Multi-Omics Market Concentration Ratio
3.4.1 Global Single Cell Multi-Omics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Multi-Omics Revenue in 2023
3.5 Single Cell Multi-Omics Key Players Head office and Area Served
3.6 Key Players Single Cell Multi-Omics Product Solution and Service
3.7 Date of Enter into Single Cell Multi-Omics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell Multi-Omics Breakdown Data by Type
4.1 Global Single Cell Multi-Omics Historic Market Size by Type (2019-2024)
4.2 Global Single Cell Multi-Omics Forecasted Market Size by Type (2025-2030)
5 Single Cell Multi-Omics Breakdown Data by Application
5.1 Global Single Cell Multi-Omics Historic Market Size by Application (2019-2024)
5.2 Global Single Cell Multi-Omics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single Cell Multi-Omics Market Size (2019-2030)
6.2 North America Single Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single Cell Multi-Omics Market Size by Country (2019-2024)
6.4 North America Single Cell Multi-Omics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cell Multi-Omics Market Size (2019-2030)
7.2 Europe Single Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single Cell Multi-Omics Market Size by Country (2019-2024)
7.4 Europe Single Cell Multi-Omics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Multi-Omics Market Size (2019-2030)
8.2 Asia-Pacific Single Cell Multi-Omics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single Cell Multi-Omics Market Size by Region (2019-2024)
8.4 Asia-Pacific Single Cell Multi-Omics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Cell Multi-Omics Market Size (2019-2030)
9.2 Latin America Single Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single Cell Multi-Omics Market Size by Country (2019-2024)
9.4 Latin America Single Cell Multi-Omics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Multi-Omics Market Size (2019-2030)
10.2 Middle East & Africa Single Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single Cell Multi-Omics Market Size by Country (2019-2024)
10.4 Middle East & Africa Single Cell Multi-Omics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Single Cell Multi-Omics Introduction
11.1.4 10x Genomics Revenue in Single Cell Multi-Omics Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 1CellBio
11.2.1 1CellBio Company Detail
11.2.2 1CellBio Business Overview
11.2.3 1CellBio Single Cell Multi-Omics Introduction
11.2.4 1CellBio Revenue in Single Cell Multi-Omics Business (2019-2024)
11.2.5 1CellBio Recent Development
11.3 MissionBio
11.3.1 MissionBio Company Detail
11.3.2 MissionBio Business Overview
11.3.3 MissionBio Single Cell Multi-Omics Introduction
11.3.4 MissionBio Revenue in Single Cell Multi-Omics Business (2019-2024)
11.3.5 MissionBio Recent Development
11.4 NanoString Technologies
11.4.1 NanoString Technologies Company Detail
11.4.2 NanoString Technologies Business Overview
11.4.3 NanoString Technologies Single Cell Multi-Omics Introduction
11.4.4 NanoString Technologies Revenue in Single Cell Multi-Omics Business (2019-2024)
11.4.5 NanoString Technologies Recent Development
11.5 Fluidigm Corporation
11.5.1 Fluidigm Corporation Company Detail
11.5.2 Fluidigm Corporation Business Overview
11.5.3 Fluidigm Corporation Single Cell Multi-Omics Introduction
11.5.4 Fluidigm Corporation Revenue in Single Cell Multi-Omics Business (2019-2024)
11.5.5 Fluidigm Corporation Recent Development
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Detail
11.6.2 Fluxion Biosciences Business Overview
11.6.3 Fluxion Biosciences Single Cell Multi-Omics Introduction
11.6.4 Fluxion Biosciences Revenue in Single Cell Multi-Omics Business (2019-2024)
11.6.5 Fluxion Biosciences Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Single Cell Multi-Omics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Single Cell Multi-Omics Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Celsee
11.8.1 Celsee Company Detail
11.8.2 Celsee Business Overview
11.8.3 Celsee Single Cell Multi-Omics Introduction
11.8.4 Celsee Revenue in Single Cell Multi-Omics Business (2019-2024)
11.8.5 Celsee Recent Development
11.9 BGI Genomics
11.9.1 BGI Genomics Company Detail
11.9.2 BGI Genomics Business Overview
11.9.3 BGI Genomics Single Cell Multi-Omics Introduction
11.9.4 BGI Genomics Revenue in Single Cell Multi-Omics Business (2019-2024)
11.9.5 BGI Genomics Recent Development
11.10 GE LifeSciences
11.10.1 GE LifeSciences Company Detail
11.10.2 GE LifeSciences Business Overview
11.10.3 GE LifeSciences Single Cell Multi-Omics Introduction
11.10.4 GE LifeSciences Revenue in Single Cell Multi-Omics Business (2019-2024)
11.10.5 GE LifeSciences Recent Development
11.11 Illumina
11.11.1 Illumina Company Detail
11.11.2 Illumina Business Overview
11.11.3 Illumina Single Cell Multi-Omics Introduction
11.11.4 Illumina Revenue in Single Cell Multi-Omics Business (2019-2024)
11.11.5 Illumina Recent Development
11.12 Takara Bio
11.12.1 Takara Bio Company Detail
11.12.2 Takara Bio Business Overview
11.12.3 Takara Bio Single Cell Multi-Omics Introduction
11.12.4 Takara Bio Revenue in Single Cell Multi-Omics Business (2019-2024)
11.12.5 Takara Bio Recent Development
11.13 QIAGEN N.V.
11.13.1 QIAGEN N.V. Company Detail
11.13.2 QIAGEN N.V. Business Overview
11.13.3 QIAGEN N.V. Single Cell Multi-Omics Introduction
11.13.4 QIAGEN N.V. Revenue in Single Cell Multi-Omics Business (2019-2024)
11.13.5 QIAGEN N.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
